ArticleThe Lancet regional health. Western Pacific2024

Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001-2020.

Yuxuan Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.